Literature DB >> 10840420

Clinical efficacy of combined lithoclast and lithovac stone removal during ureteroscopy.

F C Delvecchio1, R L Kuo, G M Preminger.   

Abstract

PURPOSE: Pneumatic lithotripsy has proved to be an extremely safe, efficient and low cost intracorporeal fragmentation modality. Unfortunately proximal migration of fragments into inaccessible areas in the intrarenal collecting system is a potential limitation during ureteroscopic procedures. Moreover, the lack of an efficient mechanism of stone retrieval further limits the widespread application of this technique. The newly developed Lithovacdagger suction device was designed to be combined with pneumatic lithotripsy during ureteroscopic stone removal. We evaluated the effectiveness of this combination for overcoming these limitations.
MATERIALS AND METHODS: Between February and December 1998, 21 patients underwent pneumatic lithotripsy of ureteral calculi combined with use of the Lithovac suction probe. Stone area was 20 to 320 mm.2 (mean 84). Of the stones 71% and 29% were in the distal, and proximal and/or mid ureter, respectively. We used a 0.8 mm. pneumatic lithotripsy probe placed through a 4.8Fr Lithovac probe at a pulse frequency of 12 Hz. and pressure of 2 atmospheres.
RESULTS: Mean operative time was 42 minutes and the stone fragmentation rate was 100%. There were no complications in our series and no proximal migration of fragments. The overall stone-free rate was 95% at 3-month followup.
CONCLUSIONS: Using the Lithovac suction device greatly facilitates pneumatic lithotripsy during ureteroscopic stone removal. This combination not only prevents fragment migration, but also aids in maintaining a clear endoscopic field of view, allowing efficient, safe and effective stone fragmentation.

Entities:  

Mesh:

Year:  2000        PMID: 10840420

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  [The frequency-doubled double-pulse Neodym:YAG laser lithotripter (FREDDY) in lithotripsy of urinary stones. First clinical experience].

Authors:  A Ebert; J Stangl; R Kühn; W Schafhauser
Journal:  Urologe A       Date:  2003-03-05       Impact factor: 0.639

Review 2.  Preventing stone retropulsion during intracorporeal lithotripsy.

Authors:  Osama M Elashry; Ahmad M Tawfik
Journal:  Nat Rev Urol       Date:  2012-11-20       Impact factor: 14.432

3.  Pneumatic versus laser ureteroscopic lithotripsy: a comparison of initial outcomes and cost.

Authors:  Aslan Demir; Mert Ali Karadağ; Kurşat Ceçen; Mehmet Uslu; Omer Erkam Arslan
Journal:  Int Urol Nephrol       Date:  2014-08-01       Impact factor: 2.370

Review 4.  Intracorporeal lithotripsy.

Authors:  Peter Alken
Journal:  Urolithiasis       Date:  2017-12-04       Impact factor: 3.436

5.  A comparison of Stone Cone versus lidocaine jelly in the prevention of ureteral stone migration during ureteroscopic lithotripsy.

Authors:  Mohamed Bastawisy; Tarek Gameel; Mohamed Radwan; Ahmed Ramadan; Mutie Alkathiri; Adel Omar
Journal:  Ther Adv Urol       Date:  2011-10

6.  Routine ureteral dilatation is not necessary for ureteroscopy.

Authors:  Ali Unsal; Ersin Cimentepe; M Derya Balbay
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

7.  Prevention of retrograde calculus migration with the Stone Cone.

Authors:  N P Pardalidis; A G Papatsoris; E V Kosmaoglou
Journal:  Urol Res       Date:  2004-12-30

8.  Simultaneous saline irrigation during retrograde rigid ureteroscopic lasertripsy for the prevention of proximal calculus migration.

Authors:  Lu Sun; Fang-Li Peng
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

Review 9.  Minimally Invasive Surgery for the Treatment of Ureteric Stones - State-of-the-Art Review.

Authors:  Radhika Bhanot; Patrick Jones; Bhaskar Somani
Journal:  Res Rep Urol       Date:  2021-05-06

10.  The "Guidewire-Coil"-Technique to prevent retrograde stone migration of ureteric calculi during intracorporeal lithothripsy.

Authors:  Nici Markus Dreger; Friedrich Carl von Rundstedt; Stephan Roth; Alexander Sascha Brandt; Stephan Degener
Journal:  BMC Urol       Date:  2017-01-05       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.